These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36041789)

  • 1. Financial Barriers to the Optimal Use of Peritoneal Dialysis in France and Europe, as in the United States.
    Rostoker G; Issad B
    J Am Soc Nephrol; 2022 Nov; 33(11):2125-2126. PubMed ID: 36041789
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of chronic dialysis in France on 31 December 1979. Chronic hemodialysis, peritoneal dialysis, equipment, number of patients treated].
    Méry JP
    Nephrologie; 1980; 1(3):121-5. PubMed ID: 7290295
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
    Baerman EA; Kaplan J; Shen JI; Winkelmayer WC; Erickson KF
    J Am Soc Nephrol; 2022 Jun; 33(6):1063-1072. PubMed ID: 35314456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The United States' perspectives on home dialysis.
    Qamar M; Bender F; Rault R; Piraino B
    Adv Chronic Kidney Dis; 2009 May; 16(3):189-97. PubMed ID: 19393969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of chronic extrarenal purification in France on 31 December 1980. Hemodialysis--peritoneal dialysis--equipment--number of patients treated].
    Méry JP
    Nephrologie; 1982; 3(3):127-32. PubMed ID: 7144996
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Home Dialysis the Way Forward for Medicare? Assessing Potential Cost Savings Associated with Peritoneal Dialysis.
    Tummalapalli SL; Lin E
    J Am Soc Nephrol; 2022 Nov; 33(11):1963-1965. PubMed ID: 36224033
    [No Abstract]   [Full Text] [Related]  

  • 7. Barriers and Facilitators of Home Dialysis in the Advancing American Kidney Health Era.
    Paulus AB; Finch LL
    Nephrol Nurs J; 2020; 47(6):557-563. PubMed ID: 33377757
    [No Abstract]   [Full Text] [Related]  

  • 8. Dialysis: Choice of dialysis--what to do with economic incentives.
    Chow KM; Li PK
    Nat Rev Nephrol; 2012 Sep; 8(9):495-6. PubMed ID: 22847345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of terminal-stage uremia by substitution dialysis methods in France in December 1981].
    Jacobs C; Patte R
    Nephrologie; 1983; 4(2):64-8. PubMed ID: 6877480
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialysis and transplantation in Europe.
    Wing AJ; Brunner FP; Burck HC; Gurland HJ; Parsons FM; Schärer K
    Clin Nephrol; 1975; 3(4):123-8. PubMed ID: 1097144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors determining the modality selection in dialysis].
    Kessler M; Chanliau J
    Nephrologie; 2000; 21(2):45-6. PubMed ID: 10798203
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulling the goalie: What the United States and the world can learn from Canada about growing home dialysis.
    Abra G; Weinhandl ED
    Perit Dial Int; 2021 Sep; 41(5):437-440. PubMed ID: 34323152
    [No Abstract]   [Full Text] [Related]  

  • 14. Home dialysis gets the spotlight--will it help?
    Neumann ME
    Nephrol News Issues; 2016 Apr; 30(4):8, 10. PubMed ID: 27254896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a Staff-Assisted Peritoneal Dialysis Program in the United States: A Feasibility Study.
    Hussein WF; Bennett PN; Anwaar A; Atwal J; Legg V; Abra G; Zheng S; Pravoverov L; Schiller B
    Clin J Am Soc Nephrol; 2022 May; 17(5):703-705. PubMed ID: 35383044
    [No Abstract]   [Full Text] [Related]  

  • 17. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of home dialysis in the United States.
    Rivara MB; Mehrotra R
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):586-91. PubMed ID: 25197946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Approach To Promoting Home Hemodialysis during End Stage Kidney Disease.
    Lockridge R; Weinhandl E; Kraus M; Schreiber M; Spry L; Tailor P; Carver M; Glickman J; Miller B
    Kidney360; 2020 Sep; 1(9):993-1001. PubMed ID: 35369547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy. 11. The cost of treating chronic renal failure.
    Pincherle G
    Nurs Times; 1982 Jul 7-13; 78(27):1153-4. PubMed ID: 6920717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.